Annual CAPEX:
$17.05M+$4.49M(+35.80%)Summary
- As of today, RXRX annual capital expenditures is $17.05 million, with the most recent change of +$4.49 million (+35.80%) on December 31, 2024.
- During the last 3 years, RXRX annual CAPEX has fallen by -$22.75 million (-57.17%).
- RXRX annual CAPEX is now -57.17% below its all-time high of $39.80 million, reached on December 31, 2021.
Performance
RXRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$5.31M+$3.48M(+189.74%)Summary
- As of today, RXRX quarterly capital expenditures is $5.31 million, with the most recent change of +$3.48 million (+189.74%) on June 30, 2025.
- Over the past year, RXRX quarterly CAPEX has increased by +$1.13 million (+26.92%).
- RXRX quarterly CAPEX is now -72.66% below its all-time high of $19.42 million, reached on March 31, 2021.
Performance
RXRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$13.35M+$1.13M(+9.21%)Summary
- As of today, RXRX TTM capital expenditures is $13.35 million, with the most recent change of +$1.13 million (+9.21%) on June 30, 2025.
- Over the past year, RXRX TTM CAPEX has dropped by -$729.00 thousand (-5.18%).
- RXRX TTM CAPEX is now -66.46% below its all-time high of $39.80 million, reached on December 31, 2021.
Performance
RXRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RXRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +35.8% | +26.9% | -5.2% |
| 3Y3 Years | -57.2% | -67.8% | -61.8% |
| 5Y5 Years | +335.9% | +737.2% | +522.7% |
RXRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -57.2% | +35.8% | -38.0% | +541.8% | -65.2% | +9.2% |
| 5Y | 5-Year | -57.2% | +335.9% | -72.7% | +542.6% | -66.5% | +522.7% |
| All-Time | All-Time | -57.2% | +335.9% | -72.7% | +737.2% | -66.5% | +1851.8% |
RXRX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.31M(+189.7%) | $13.35M(+9.2%) |
| Mar 2025 | - | $1.83M(+11.2%) | $12.22M(-28.3%) |
| Dec 2024 | $17.05M(+35.8%) | $1.65M(-63.9%) | $17.05M(-4.3%) |
| Sep 2024 | - | $4.56M(+9.1%) | $17.81M(+26.5%) |
| Jun 2024 | - | $4.18M(-37.1%) | $14.08M(+1.5%) |
| Mar 2024 | - | $6.65M(+175.3%) | $13.87M(+10.5%) |
| Dec 2023 | $12.55M(-66.4%) | $2.42M(+192.3%) | $12.55M(-30.7%) |
| Sep 2023 | - | $827.00K(-79.2%) | $18.11M(-29.9%) |
| Jun 2023 | - | $3.97M(-25.7%) | $25.85M(-32.6%) |
| Mar 2023 | - | $5.34M(-33.1%) | $38.36M(+2.7%) |
| Dec 2022 | $37.36M | $7.98M(-6.8%) | $37.36M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $8.56M(-48.0%) | $33.84M(-3.3%) |
| Jun 2022 | - | $16.48M(+279.4%) | $34.99M(+41.5%) |
| Mar 2022 | - | $4.34M(-2.7%) | $24.72M(-37.9%) |
| Dec 2021 | $39.80M(+490.9%) | $4.46M(-54.0%) | $39.80M(+12.6%) |
| Sep 2021 | - | $9.71M(+56.2%) | $35.33M(+33.6%) |
| Jun 2021 | - | $6.21M(-68.0%) | $26.45M(+26.7%) |
| Mar 2021 | - | $19.42M(+2250.6%) | $20.88M(+873.7%) |
| Dec 2020 | $6.74M(+72.3%) | - | - |
| Sep 2020 | - | $826.00K(+30.3%) | $2.14M(+62.7%) |
| Jun 2020 | - | $634.00K(-7.3%) | $1.32M(+92.7%) |
| Mar 2020 | - | $684.00K | $684.00K |
| Dec 2019 | $3.91M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual CAPEX year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual capital expenditures?
The current annual CAPEX of RXRX is $17.05M
What is the all-time high annual CAPEX for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual capital expenditures is $39.80M
What is Recursion Pharmaceuticals, Inc. annual CAPEX year-on-year change?
Over the past year, RXRX annual capital expenditures has changed by +$4.49M (+35.80%)
What is Recursion Pharmaceuticals, Inc. quarterly capital expenditures?
The current quarterly CAPEX of RXRX is $5.31M
What is the all-time high quarterly CAPEX for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $19.42M
What is Recursion Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
Over the past year, RXRX quarterly capital expenditures has changed by +$1.13M (+26.92%)
What is Recursion Pharmaceuticals, Inc. TTM capital expenditures?
The current TTM CAPEX of RXRX is $13.35M
What is the all-time high TTM CAPEX for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM capital expenditures is $39.80M
What is Recursion Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
Over the past year, RXRX TTM capital expenditures has changed by -$729.00K (-5.18%)